Publication | Closed Access

The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis

OncologySynergistic Anti-proliferative EffectMedicinePharmacologyColorectal CancerPathologyCancer Cell BiologyPi3k/akt/mtor/nf-κb AxisAnti-cancer AgentCancer BiologyCancer Research